Related Experiment Video
Updated: May 31, 2026

Measuring Post-Stroke Cerebral Edema, Infarct Zone and Blood-Brain Barrier Breakdown in a Single Set of Rodent Brain Samples
Published on: October 23, 2020
Value of biomarker-based diagnostic test in differential diagnosis of hemorrhagic-ischemic stroke
C Kavalci1, H Genchallac, P Durukan
1Trakya University Faculty of Medicine, Emergency Department, Edirne, Turkey. cemkavalci@yahoo.com
Insights
A novel stroke panel combining BNP, D-dimer, MMP-9, and S-100b shows promise in differentiating acute hemorrhagic stroke from ischemic stroke. This biomarker combination aids in rapid diagnosis for better patient outcomes.
Area of Science:
- Neurology
- Emergency Medicine
- Biochemistry
Background:
- Stroke is a leading cause of death and disability.
- Accurate and rapid diagnosis is critical for effective treatment.
- Differentiating between hemorrhagic and ischemic stroke is essential.
Purpose of the Study:
- To evaluate the utility of a triage stroke panel in distinguishing between acute hemorrhagic and ischemic stroke.
- To assess the diagnostic value of plasma biomarkers including BNP, D-dimer, MMP-9, and S-100b.
Main Methods:
- Prospective recruitment of 100 acute stroke patients in the Emergency Department.
- Assay of plasma biomarkers: BNP, D-dimer, MMP-9, and S-100b.
- Statistical analysis using Pearson's chi2 and Mann-Whitney U/Kruskal-Wallis tests.
Main Results:
- 29% of patients had hemorrhagic stroke, 71% had ischemic stroke.
- A combined evaluation of BNP, D-dimer, MMP-9, and S-100b demonstrated significant importance in differential diagnosis (p < 0.005).
Conclusions:
- A combination of plasma biomarkers can be useful for the differential diagnosis of ischemic versus hemorrhagic stroke.
- This panel offers a potential tool for rapid stroke subtyping in emergency settings.
Background And Aim:
Stroke is an emergency which threatens life and the third leading cause of death in developed countries and the leading cause of long-term disability. By means of this study, it was aimed to evaluate the position of triage stroke panel in differential diagnosis of acute hemorrhagic stroke and ischemic stroke and sub-types of ischemic stroke.
Material And Methods:
Patients with acute stroke admitted to Emergency Department were prospectively recruited between June 2008-January 2009. BNP, D-dimer, MMP-9, S-100b levels were asseyed. Statistical significance for intergroup differences was assessed by Pearson's chi2 for categorical variables and Mann-Whitney U test or Kruskal-Wallis test for continuous variables.
Results And Conclusion:
A total of 100 consecutive patients with a diagnosis of stroke were evaluated. Of these, 29 (29%) patients had brain hemorrhages on the computed tomography scan performed the Emergency Department, 71 (71%) patients had ischemic stroke. It was observed that the intercept obtained as a result of jointly evaluating BNP, D-dimer, MMP9 and S100b is more important in differential diagnosis (p < 0.005). We suggest that using a combination of plasma biomarkers may be usefull to ischemic or hemorrhagic stroke for differential diagnosis (Tab. 4, Ref. 22).
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

